IL-1 family cytokines in cardiovascular disease.


Journal

Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353

Informations de publication

Date de publication:
10 2019
Historique:
received: 03 08 2017
revised: 13 11 2017
accepted: 15 11 2017
pubmed: 5 12 2017
medline: 10 9 2020
entrez: 5 12 2017
Statut: ppublish

Résumé

The interleukin (IL)-1 family is a group of cytokines crucially involved in regulating immune responses to infectious challenges and sterile insults. The family consists of the eponymous pair IL-1α and IL-1β, IL-18, IL-33, IL-37, IL-38, and several isoforms of IL-36. In addition, two endogenous inhibitors of functional receptor binding, IL-1R antagonist (IL-1Ra) and IL-36Ra complete the family. To gain biological activity IL-1β and IL-18 require processing by the protease caspase-1 which is associated with the multi-protein complex inflammasome. Numerous clinical association studies and experimental approaches have implicated members of the IL-1 family, their receptors, or component of the processing machinery in underlying processes of cardiovascular diseases (CVDs). Here we summarize the current state of knowledge regarding the pro-inflammatory and disease-modulating role of the IL-1 family in atherosclerosis, myocardial infarction, aneurysm, stroke, and other CVDs. We discuss clinical evidence, experimental approaches and lastly lend a perspective on currently developing therapeutic strategies involving the IL-1 family in CVD.

Identifiants

pubmed: 29198612
pii: S1043-4666(17)30351-4
doi: 10.1016/j.cyto.2017.11.009
pii:
doi:

Substances chimiques

Cytokines 0
IL1A protein, human 0
IL1B protein, human 0
Inflammasomes 0
Interleukin-1alpha 0
Interleukin-1beta 0
Caspase 1 EC 3.4.22.36

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

154215

Informations de copyright

Copyright © 2017 Elsevier Ltd. All rights reserved.

Auteurs

Susanne Pfeiler (S)

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.

Holger Winkels (H)

Division of Inflammation Biology, La Jolla Institute for Allergy & Immunology, La Jolla, CA, United States.

Malte Kelm (M)

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany.

Norbert Gerdes (N)

Division of Cardiology, Pulmonology, and Vascular Medicine, Medical Faculty, University Hospital Düsseldorf, Düsseldorf, Germany; Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany. Electronic address: norbert.gerdes@med.uni-duesseldorf.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH